We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Celsion Corporation announced that Lawrence Olanoff, M.D., Ph.D., its President and Chief Executive Officer has tendered his resignation from executive management effective October 6, 2006 to return to Forest Laboratories Inc. as President and Chief Operating Officer.
People taking Oxycontin, codeine and other powerful painkillers for chronic pain could get a 90-day supply, under a proposal Wednesday that would let patients avoid repeated doctor visits to get more than 30-day prescriptions.
A Pfizer Inc. drug received the endorsement of a panel of government advisers Wednesday for use in preventing some blood clots that can prove deadly for cancer patients.
Apotex Inc. filed an appeal late Wednesday against the injunction preventing the Canadian drug company from selling a generic version of the heart drug Plavix.
A unit of Barr Pharmaceuticals Inc. plans to make a generic version of its own contraceptive Seasonale after the Food and Drug Administration gave another company permission to manufacture a generic brand of the drug.
A Norwegian court Aug. 29 ruled that Ranbaxy's generic version of Pfizer's blockbuster cholesterol drug Lipitor does not infringe on two of Pfizer's patents for the medication -- however, another patent remains in effect that will not allow Ranbaxy to launch a generic version of the drug in Norway until 2009.
A trade group's failure to make good on a commitment to the FDA has, in part, resulted in a decision by the agency to remove OTC status for all skin-bleaching creams because some contain a chemical that may cause cancer, according to the FDA.
The Senate will soon address a number of important pieces of healthcare legislation, with an eye toward addressing these bills before the midterm elections in November, congressional sources say.